 This is a prospective, non-interventional, multi center post-authorization safety study that includes patients with a diagnosis of myopic choroidal neovascularization. The investigator will have made the choice of treatment EYLEA as well as the decision to use EYLEA according the Japanese Package Insert prior to enrolling the patient in this study. 